Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Members of Marinobacter and Arcobacter Influence System Biogeochemistry During Early Production of Hydraulically Fractured Natural Gas Wells in the Appalachian Basin.

Evans MV, Panescu J, Hanson AJ, Welch SA, Sheets JM, Nastasi N, Daly RA, Cole DR, Darrah TH, Wilkins MJ, Wrighton KC, Mouser PJ.

Front Microbiol. 2018 Nov 15;9:2646. doi: 10.3389/fmicb.2018.02646. eCollection 2018.

2.

Degradation of polyethylene glycols and polypropylene glycols in microcosms simulating a spill of produced water in shallow groundwater.

Rogers JD, Thurman EM, Ferrer I, Rosenblum JS, Evans MV, Mouser PJ, Ryan JN.

Environ Sci Process Impacts. 2019 Feb 21;21(2):256-268. doi: 10.1039/c8em00291f.

PMID:
30318550
3.

Spatio-temporal spillover risk of yellow fever in Brazil.

Kaul RB, Evans MV, Murdock CC, Drake JM.

Parasit Vectors. 2018 Aug 29;11(1):488. doi: 10.1186/s13071-018-3063-6.

4.

Carry-over effects of urban larval environments on the transmission potential of dengue-2 virus.

Evans MV, Shiau JC, Solano N, Brindley MA, Drake JM, Murdock CC.

Parasit Vectors. 2018 Jul 17;11(1):426. doi: 10.1186/s13071-018-3013-3.

5.

Anticipating Emerging Mosquito-borne Flaviviruses in the USA: What Comes after Zika?

Evans MV, Murdock CC, Drake JM.

Trends Parasitol. 2018 Jul;34(7):544-547. doi: 10.1016/j.pt.2018.02.010. Epub 2018 Mar 15.

PMID:
29551358
6.

Natural Attenuation of Nonionic Surfactants Used in Hydraulic Fracturing Fluids: Degradation Rates, Pathways, and Mechanisms.

Heyob KM, Blotevogel J, Brooker M, Evans MV, Lenhart JJ, Wright J, Lamendella R, Borch T, Mouser PJ.

Environ Sci Technol. 2017 Dec 5;51(23):13985-13994. doi: 10.1021/acs.est.7b01539. Epub 2017 Nov 13.

PMID:
29110455
7.

A physiologically based pharmacokinetic model of vitamin D.

Sawyer ME, Tran HT, Evans MV.

J Appl Toxicol. 2017 Dec;37(12):1448-1454. doi: 10.1002/jat.3489. Epub 2017 Jun 6.

8.

Fine-scale variation in microclimate across an urban landscape shapes variation in mosquito population dynamics and the potential of Aedes albopictus to transmit arboviral disease.

Murdock CC, Evans MV, McClanahan TD, Miazgowicz KL, Tesla B.

PLoS Negl Trop Dis. 2017 May 30;11(5):e0005640. doi: 10.1371/journal.pntd.0005640. eCollection 2017 May.

9.

Detecting the impact of temperature on transmission of Zika, dengue, and chikungunya using mechanistic models.

Mordecai EA, Cohen JM, Evans MV, Gudapati P, Johnson LR, Lippi CA, Miazgowicz K, Murdock CC, Rohr JR, Ryan SJ, Savage V, Shocket MS, Stewart Ibarra A, Thomas MB, Weikel DP.

PLoS Negl Trop Dis. 2017 Apr 27;11(4):e0005568. doi: 10.1371/journal.pntd.0005568. eCollection 2017 Apr.

10.

Data-driven identification of potential Zika virus vectors.

Evans MV, Dallas TA, Han BA, Murdock CC, Drake JM.

Elife. 2017 Feb 28;6. pii: e22053. doi: 10.7554/eLife.22053.

11.

Development of a human physiologically based pharmacokinetic (PBPK) model for dermal permeability for lindane.

Sawyer ME, Evans MV, Wilson CA, Beesley LJ, Leon LS, Eklund CR, Croom EL, Pegram RA.

Toxicol Lett. 2016 Mar 14;245:106-9. doi: 10.1016/j.toxlet.2016.01.008. Epub 2016 Jan 18.

PMID:
26794662
12.

Improving in vitro to in vivo extrapolation by incorporating toxicokinetic measurements: a case study of lindane-induced neurotoxicity.

Croom EL, Shafer TJ, Evans MV, Mundy WR, Eklund CR, Johnstone AF, Mack CM, Pegram RA.

Toxicol Appl Pharmacol. 2015 Feb 15;283(1):9-19. doi: 10.1016/j.taap.2014.11.006. Epub 2014 Dec 18.

PMID:
25529470
13.

Scientific considerations for evaluating cancer bioassays conducted by the Ramazzini Institute.

Gift JS, Caldwell JC, Jinot J, Evans MV, Cote I, Vandenberg JJ.

Environ Health Perspect. 2013 Nov-Dec;121(11-12):1253-63. doi: 10.1289/ehp.1306661. Epub 2013 Sep 17. Review.

14.

State of the science: biologically based modeling in risk assessment.

Caldwell JC, Krishnan K, Evans MV.

J Toxicol. 2012;2012:758182. doi: 10.1155/2012/758182. Epub 2012 Nov 28. No abstract available.

15.

Human health effects of trichloroethylene: key findings and scientific issues.

Chiu WA, Jinot J, Scott CS, Makris SL, Cooper GS, Dzubow RC, Bale AS, Evans MV, Guyton KZ, Keshava N, Lipscomb JC, Barone S Jr, Fox JF, Gwinn MR, Schaum J, Caldwell JC.

Environ Health Perspect. 2013 Mar;121(3):303-11. doi: 10.1289/ehp.1205879. Epub 2012 Dec 18. Review.

16.

Cutting Edge PBPK Models and Analyses: Providing the Basis for Future Modeling Efforts and Bridges to Emerging Toxicology Paradigms.

Caldwell JC, Evans MV, Krishnan K.

J Toxicol. 2012;2012:852384. doi: 10.1155/2012/852384. Epub 2012 Jul 30.

17.

Physiologically Based Pharmacokinetic (PBPK) Modeling of Metabolic Pathways of Bromochloromethane in Rats.

Cuello WS, Janes TA, Jessee JM, Venecek MA, Sawyer ME, Eklund CR, Evans MV.

J Toxicol. 2012;2012:629781. doi: 10.1155/2012/629781. Epub 2012 Apr 11.

18.
20.

Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.

Evans MV, Chiu WA, Okino MS, Caldwell JC.

Toxicol Appl Pharmacol. 2009 May 1;236(3):329-40. doi: 10.1016/j.taap.2009.02.013. Epub 2009 Feb 26.

PMID:
19249323
21.

A physiologically based pharmacokinetic model for intravenous and ingested dimethylarsinic acid in mice.

Evans MV, Dowd SM, Kenyon EM, Hughes MF, El-Masri HA.

Toxicol Sci. 2008 Aug;104(2):250-60. doi: 10.1093/toxsci/kfn080. Epub 2008 Apr 21.

PMID:
18430741
22.
23.
24.

Issues in the pharmacokinetics of trichloroethylene and its metabolites.

Chiu WA, Okino MS, Lipscomb JC, Evans MV.

Environ Health Perspect. 2006 Sep;114(9):1450-6. Review.

25.

Comments on article "Applying mode-of-action and pharmacokinetic considerations in contemporary cancer risk assessments: an example with trichloroethylene" by Clewell and Andersen.

Caldwell JC, Evans MV, Marcus AH, Scott CS, Chiu WA, Okino MS, Preuss PW.

Crit Rev Toxicol. 2006 Mar;36(3):291-4; discussion 295-8.

PMID:
16686425
26.

Duration adjustment of acute exposure guideline level values for trichloroethylene using a physiologically-based pharmacokinetic model.

Boyes WK, Evans MV, Eklund C, Janssen P, Simmons JE.

Risk Anal. 2005 Jun;25(3):677-86.

PMID:
16022699
27.
28.

Genotoxicity and metabolism of the source-water contaminant 1,1-dichloropropene: activation by GSTT1-1 and structure-activity considerations.

Granville CA, Ross MK, Tornero-Velez R, Hanley NM, Grindstaff RD, Gold A, Richard AM, Funasaka K, Tennant AH, Kligerman AD, Evans MV, DeMarini DM.

Mutat Res. 2005 May 2;572(1-2):98-112.

PMID:
15790493
29.

Visualization-based analysis for a mixed-inhibition binary PBPK model: determination of inhibition mechanism.

Isaacs KK, Evans MV, Harris TR.

J Pharmacokinet Pharmacodyn. 2004 Jun;31(3):215-42.

PMID:
15518245
30.

The metabolic rate constants and specific activity of human and rat hepatic cytochrome P-450 2E1 toward toluene and chloroform.

Lipscomb JC, Barton HA, Tornero-Velez R, Evans MV, Alcasey S, Snawder JE, Laskey J.

J Toxicol Environ Health A. 2004 Apr 9;67(7):537-53.

PMID:
15129551
31.

Kinetic modeling of beta-chloroprene metabolism: II. The application of physiologically based modeling for cancer dose response analysis.

Himmelstein MW, Carpenter SC, Evans MV, Hinderliter PM, Kenyon EM.

Toxicol Sci. 2004 May;79(1):28-37. Epub 2004 Feb 19.

PMID:
14976335
32.

Metabolism and mutagenicity of source water contaminants 1,3-dichloropropane and 2,2-dichloropropane.

Tornero-Velez R, Ross MK, Granville C, Laskey J, Jones JP, DeMarini DM, Evans MV.

Drug Metab Dispos. 2004 Jan;32(1):123-31.

PMID:
14709629
33.

Pharmacokinetic modeling of arsenite uptake and metabolism in hepatocytes--mechanistic insights and implications for further experiments.

Easterling MR, Styblo M, Evans MV, Kenyon EM.

J Pharmacokinet Pharmacodyn. 2002 Jun;29(3):207-34.

PMID:
12449496
34.

A physiologically based pharmacokinetic model for trichloroethylene in the male long-evans rat.

Simmons JE, Boyes WK, Bushnell PJ, Raymer JH, Limsakun T, McDonald A, Sey YM, Evans MV.

Toxicol Sci. 2002 Sep;69(1):3-15.

PMID:
12215655
35.

A comparison of Haber's rule at different ages using a physiologically based pharmacokinetic (PBPK) model for chloroform in rats.

Evans MV, Boyes WK, Simmons JE, Litton DK, Easterling MR.

Toxicology. 2002 Jul 1;176(1-2):11-23.

PMID:
12062926
36.

Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue.

Albanese RA, Banks HT, Evans MV, Potter LK.

Bull Math Biol. 2002 Jan;64(1):97-131.

PMID:
11868339
37.

Application of modelling techniques to the planning of in vitro arsenic kinetic studies.

Kenyon EM, Fea M, Styblo M, Evans MV.

Altern Lab Anim. 2001 Jan-Feb;29(1):15-33.

PMID:
11178572
39.

Effects of aging on cardiac output, regional blood flow, and body composition in Fischer-344 rats.

Delp MD, Evans MV, Duan C.

J Appl Physiol (1985). 1998 Nov;85(5):1813-22.

41.

Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.

Wang X, Santostefano MJ, Evans MV, Richardson VM, Diliberto JJ, Birnbaum LS.

Toxicol Appl Pharmacol. 1997 Nov;147(1):151-68.

PMID:
9356318
43.

Modeling the cytochrome P450-mediated metabolism of chlorinated volatile organic compounds.

Waller CL, Evans MV, McKinney JD.

Drug Metab Dispos. 1996 Feb;24(2):203-10.

PMID:
8742232
44.

Applications of sensitivity analysis to a physiologically based pharmacokinetic model for carbon tetrachloride in rats.

Evans MV, Crank WD, Yang HM, Simmons JE.

Toxicol Appl Pharmacol. 1994 Sep;128(1):36-44.

PMID:
8079352
45.

Time shift in ventilation-induced density fluctuation of arterial blood.

Evans MV, Lee JS, Lee LP.

Ann Biomed Eng. 1987;15(1):1-17.

PMID:
3578956
46.

A density method to quantify pulmonary microvascular hematocrit.

Lee JS, Lee LP, Evans MV, Gamas L.

Microvasc Res. 1985 Sep;30(2):222-34.

PMID:
4046871

Supplemental Content

Loading ...
Support Center